The Patent Finder

Debiopharm S.A.

Also on record
Records under this name other than patents Debiopharm S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Debiopharm S.A.

PatentTitleStatus Expires Confidence
US 10,188,696Pharmaceutical Compositions
Formerly held
Lapsed on the fee record
Ended Jan 29, 2023 · High confidence
Lapsed on the fee recordEnded Jan 29, 2023High confidence
US 8,211,940Oxaliplatin active substance with a very low content of oxalic acid
Term ended
Term ended Jul 2, 2022 · From the USPTO record
Term endedTerm ended Jul 2, 2022From the USPTO record
US 7,012,072Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
Term ended
Term ended Mar 7, 2022 · From the USPTO record
Term endedTerm ended Mar 7, 2022From the USPTO record
US 7,070,796Pharmaceutically stable oxaliplatinum preparation for parenteral administration
Term ended
Term ended Jan 28, 2022 · From the USPTO record
Term endedTerm ended Jan 28, 2022From the USPTO record
US 6,989,438Process for the purification of EPI-HNE proteins
Formerly held
Term ended
Term ended Dec 21, 2021 · From the USPTO record
Term endedTerm ended Dec 21, 2021From the USPTO record
US 6,814,982Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
Formerly held
Term ended
Term ended Oct 26, 2021 · From the USPTO record
Term endedTerm ended Oct 26, 2021From the USPTO record
US 8,450,281Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy
Lapsed on the fee record
Ended May 28, 2021 · From the USPTO record
Lapsed on the fee recordEnded May 28, 2021From the USPTO record
US 6,866,857Oxalipatinum preparation packaging
Term ended
Term ended Oct 13, 2019 · From the USPTO record
Term endedTerm ended Oct 13, 2019From the USPTO record
US RE40,987Cyclosporin with improved activity profile
Term ended
Term ended Jun 30, 2019 · From the USPTO record
Term endedTerm ended Jun 30, 2019From the USPTO record
US 8,962,637Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors
Formerly held
Lapsed on the fee record
Ended Feb 24, 2019 · From the USPTO record
Lapsed on the fee recordEnded Feb 24, 2019From the USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited